Abstract
The present disclosure relates to a novel crystalline polymorph of Pirtobrutinib of formula-1 which is represented by the following structural formula-1 and process for preparation thereof.
Formula-1.
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.
Recommended Citation
MSN Laboratories Private Limited, R&D Center; Srinivasan Thirumalai Rajan; Sagyam Rajeshwar Reddy; Kammari Balraju and Garai Abhijit, "Novel crystalline form of Pirtobrutinib and its process for preparation", Technical Disclosure Commons, (December 09, 2024)
https://www.tdcommons.org/dpubs_series/7638